BRIEF-Sanofi And Regeneron Offer Praluent At New Reduced U.S. List Price

by Reuters
Monday, 11 February 2019 12:11 GMT

Feb 11 (Reuters) - Sanofi:

* SANOFI AND REGENERON OFFER PRALUENT AT NEW REDUCED U.S. LIST PRICE

* SANOFI - PRALUENT TO BE MADE AVAILABLE AT REDUCED U.S. LIST PRICE OF $5,850 ANNUALLY, DOWN 60 PERCENT FROM ORIGINAL PRICE, FOR BOTH 75 MG AND 150 MG DOSES

* NEW LOWER-PRICED PRALUENT IS EXPECTED TO BE AVAILABLE FOR PHARMACIES TO ORDER IN EARLY MARCH

* PRALUENT'S OUT-OF-POCKET COSTS FOR MEDICARE PATIENTS COULD BE LOWERED TO ABOUT $25 TO $150 PER MONTH, DEPENDING ON THEIR INSURANCE PLAN Source text for Eikon: Further company coverage:

Our Standards: The Thomson Reuters Trust Principles.